Undervalued Copper Stock could Be Set for Another 600% Run
Small Company, Big Profit Opportunity in American's Hottest Mining Spot

This may be one of the most undervalued copper stocks on the market
Get the insider scoop!

AZYO Insider Trading (Aziyo Biologics)

Insider Ownership Percentage: 45.00%
Insider Buying (Last 12 Months): $115,120.75
Insider Selling (Last 12 Months): $0.00

Aziyo Biologics Insider Trading History Chart

This chart shows the insider buying and selling history at Aziyo Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aziyo Biologics Share Price & Price History

Current Price: $5.62
Price Change: Price Decrease of -0.34 (-5.70%)
As of 10/27/2021 05:00 PM ET

This chart shows the closing price history over time for AZYO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Fake meat? This company is cornering the plant-based market
This could become one of the greatest growth stories of our lifetimes

This tiny plant-based firm has explosive growth
Get the FREE investor deck

Aziyo Biologics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2021Matthew FergusonCFOBuy1,300$11.14$14,482.001,300View SEC Filing Icon  
5/7/2021Ronald K. LloydCEOBuy8,565$11.75$100,638.7521,784View SEC Filing Icon  
10/13/2020Highcape Capital, L.P.Major ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing Icon  
See Full Table
Insider Trading at Aziyo Biologics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aziyo Biologics and related companies.

SEC Filings (Institutional Ownership Changes) for Aziyo Biologics (NASDAQ:AZYO)

20.06% of Aziyo Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AZYO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aziyo Biologics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/25/2021Perkins Capital Management Inc.228,425$1.59M1.0%+47.9%2.233%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP873,159$8.39M2.3%+49.6%8.536%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley3,295$32K0.0%+370.0%0.032%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC83,253$0.80M0.0%+288.2%0.814%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC16,503$0.16M0.0%-59.4%0.161%Search for SEC Filing on Google Icon
8/17/2021Man Group plc10,214$98K0.0%-45.0%0.100%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley3,295$32K0.0%+370.0%0.032%Search for SEC Filing on Google Icon
8/13/2021AWM Investment Company Inc.175,650$1.69M0.2%+64.0%1.717%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.55,261$0.53M0.0%-14.5%0.540%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC10,000$96K0.0%N/A0.098%Search for SEC Filing on Google Icon
8/10/2021Birchview Capital LP30,000$0.29M0.2%N/A0.293%Search for SEC Filing on Google Icon
8/9/2021O Shaughnessy Asset Management LLC2,871$28K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC40,694$0.56M0.0%-56.3%0.398%Search for SEC Filing on Google Icon
5/18/2021Man Group plc18,582$0.26M0.0%N/A0.182%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP583,600$8.07M2.1%+43.0%5.706%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC21,445$0.30M0.0%-78.7%0.210%Search for SEC Filing on Google Icon
5/13/2021AWM Investment Company Inc.107,077$1.48M0.2%-58.4%1.047%Search for SEC Filing on Google Icon
5/13/2021Platinum Investment Management Ltd.141,395$1.95M0.0%N/A1.383%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp25,230$0.35M0.0%+13.0%0.247%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.46,953$0.65M0.0%+53.2%0.459%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP13,679$0.19M0.0%N/A0.134%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.6,108$83K0.0%N/A0.060%Search for SEC Filing on Google Icon
2/16/2021Walleye Capital LLC100,803$1.37M0.1%N/A0.986%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC11,931$0.16M0.0%N/A0.117%Search for SEC Filing on Google Icon
2/16/2021Endurant Capital Management LP408,213$5.56M2.0%N/A3.992%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP10,000$0.14M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP10,000$0.14M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/12/2021AWM Investment Company Inc.257,377$3.51M0.4%N/A2.517%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp22,337$0.30M0.0%N/A0.218%Search for SEC Filing on Google Icon
2/9/2021Perkins Capital Management Inc.139,375$1.90M1.2%N/A1.363%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund5,900$80K0.0%N/A0.058%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.30,644$0.42M0.0%N/A0.300%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Read More on Aziyo Biologics

Today's Range

Now: $5.62
Low: $5.54
High: $5.99

50 Day Range

MA: $7.66
Low: $5.37
High: $9.23

52 Week Range

Now: $5.62
Low: $5.07
High: $18.20

Volume

13,704 shs

Average Volume

20,782 shs

Market Capitalization

$57.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aziyo Biologics?

Aziyo Biologics' top insider shareholders include:
  1. Ronald K Lloyd (CEO)
  2. Matthew Ferguson (CFO)
  3. Highcape Capital, LP (Major Shareholder)

Who are the major institutional investors of Aziyo Biologics?

Aziyo Biologics' top institutional shareholders include:
  1. Perkins Capital Management Inc. — 2.23%

Which major investors are buying Aziyo Biologics stock?

During the last quarter, AZYO stock was bought by institutional investors including:
  1. Perkins Capital Management Inc.
In the previous year, these company insiders have bought Aziyo Biologics stock:
  1. Ronald K Lloyd (CEO)
  2. Matthew Ferguson (CFO)
  3. Highcape Capital, LP (Major Shareholder)
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021